FDA Clearance Tracker · P170002-S050
RHA Redensity® Eye Lido; RHA Redensity® Eye
Last checked: Nov 20, 2026Latest source record: May 12, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 12, 2026
Approved
Time to decision
256 days
Received Aug 29, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P170002-S050
- Device name
- RHA Redensity® Eye Lido; RHA Redensity® Eye
- Applicant
- Teoxane S.A.
- Applicant location
- Geneva
- Received
- Aug 29, 2025
- Decided
- May 12, 2026
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P170002
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for RHA Redensity® Eye Lido and RHA Redensity® Eye for expanding the indications to include injection into the sub-dermis and supraperiosteum for the correction of moderate to severe tissue volume deficiencies in the infraorbital region in adults aged 22 years or older.
Source documents
Other decisions for Teoxane S.A.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- RHA® Dynamic Volume, RHA®4PMA supplement
P170002-S048 · Decided Sep 18, 2025 · 290 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- RHA®3 dermal fillerPMA supplement
P170002-S030 · Decided Oct 27, 2023 · 179 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- RHA® Redensity Mepi, RHA®2 Mepi, RHA®3 Mepi, RHA®4 MepiPMA supplement
P170002-S026 · Decided Oct 13, 2023 · 240 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.